Univ. Lille, CNRS, INRAE, Centrale Lille, UMR 8207 - UMET - Unité Matériaux et Transformations, F-59000 Lille, France.
J Pharm Sci. 2020 Sep;109(9):2640-2653. doi: 10.1016/j.xphs.2020.05.021. Epub 2020 Jun 2.
A review of work on pharmaceutical molecular materials studied under high pressure was carried out. The behavior of the crystallographic structure of these materials is observed under high pressure thanks to X-ray diffraction laboratory, synchrotron experiments or Raman spectroscopy. In particular, the highlighting of phase transitions and the discovery of new crystallographic forms are an important application of these methods. Works performed from the last two decades shows that two ways are mainly used: direct compression of powders or single crystals and crystallization under high pressure in different solvents. The evolution of the cell volumes and lattice parameters of different compounds have been observed with direct compression experiments of the order of few GPa to few tens of GPa. On few compounds the discovery of new polymorphic forms is highlighted. High pressure crystallization experiments generally require lower pressure ranges, on the order of few hundred to few GPa. For numerous pharmaceutical molecules, new polymorphs but also salts, solvates, hydrates or co-crystals can be obtained. It depends on the solvents and pressure ranges chosen. It shows the possibility to select the desired crystallographic form of a given active principle by a judicious choice of these parameters.
对高压下研究的药物分子材料进行了文献回顾。由于 X 射线衍射实验室、同步辐射实验或拉曼光谱学,这些材料的晶体结构行为在高压下得到了观察。特别是,相变的突出和新晶体形式的发现是这些方法的一个重要应用。过去二十年的研究表明,主要使用两种方法:粉末或单晶的直接压缩和在不同溶剂中高压下的结晶。通过几 GPa 到几十 GPa 的直接压缩实验观察了不同化合物的晶胞体积和晶格参数的演变。对少数化合物发现了新的多晶型形式。高压结晶实验通常需要较低的压力范围,约几百到几 GPa。对于许多药物分子,可以获得新的多晶型物、盐、溶剂化物、水合物或共晶。这取决于所选的溶剂和压力范围。这表明通过明智地选择这些参数,可以选择给定活性成分的所需晶体形式。